Paul H. Huang

10.2k total citations · 2 hit papers
126 papers, 4.2k citations indexed

About

Paul H. Huang is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Paul H. Huang has authored 126 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Pulmonary and Respiratory Medicine, 57 papers in Oncology and 46 papers in Molecular Biology. Recurrent topics in Paul H. Huang's work include Sarcoma Diagnosis and Treatment (56 papers), CAR-T cell therapy research (20 papers) and Vascular Tumors and Angiosarcomas (18 papers). Paul H. Huang is often cited by papers focused on Sarcoma Diagnosis and Treatment (56 papers), CAR-T cell therapy research (20 papers) and Vascular Tumors and Angiosarcomas (18 papers). Paul H. Huang collaborates with scholars based in United Kingdom, United States and Italy. Paul H. Huang's co-authors include Simon Vyse, Robin L. Jones, Forest M. White, Alexander M. Xu, Lukáš Krásný, Leo S. Payne, Khin Thway, Frank B. Furnari, Webster K. Cavenee and Ryan A. Flynn and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Paul H. Huang

118 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer

2019 397 citations Simon Vyse, Paul H. Huang et al. profile →
Future Directions in the Treatment of Osteosarcoma

2021 160 citations Alannah Smrke, Paul H. Huang et al. Cells profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul H. Huang United Kingdom	31	2.1k	1.5k	1.5k	701	431	126	4.2k
Bjørn Risberg Norway	41	1.8k 0.9×	1.4k 0.9×	761 0.5×	877 1.3×	438 1.0×	131	4.6k
George N. Naumov United States	22	1.9k 0.9×	2.3k 1.6×	1.3k 0.9×	1.1k 1.6×	291 0.7×	37	4.0k
Deric L. Wheeler United States	37	2.5k 1.2×	2.5k 1.7×	1.3k 0.9×	751 1.1×	320 0.7×	89	4.8k
Eric A. Severson United States	25	2.0k 1.0×	1.5k 1.0×	1.3k 0.9×	1.2k 1.6×	192 0.4×	127	4.3k
Maria Cristina Manara Italy	45	2.9k 1.4×	1.6k 1.1×	2.4k 1.6×	1.3k 1.8×	298 0.7×	117	5.5k
Tokuzo Arao Japan	38	2.2k 1.1×	1.4k 1.0×	1.1k 0.7×	771 1.1×	320 0.7×	90	3.7k
Sonja Loges Germany	35	2.7k 1.3×	1.9k 1.3×	630 0.4×	1.4k 2.1×	297 0.7×	98	5.0k
Cristina Nadal Spain	17	2.2k 1.0×	2.3k 1.6×	726 0.5×	1.3k 1.8×	283 0.7×	42	4.3k
Baocun Sun China	39	2.8k 1.4×	1.7k 1.2×	783 0.5×	1.5k 2.2×	348 0.8×	145	4.6k
Oddbjørn Straume Norway	31	2.8k 1.3×	2.4k 1.6×	694 0.5×	1.3k 1.9×	337 0.8×	69	4.6k

Countries citing papers authored by Paul H. Huang

Since Specialization

Citations

This map shows the geographic impact of Paul H. Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul H. Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul H. Huang more than expected).

Fields of papers citing papers by Paul H. Huang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul H. Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul H. Huang. The network helps show where Paul H. Huang may publish in the future.

Co-authorship network of co-authors of Paul H. Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Paul H. Huang. A scholar is included among the top collaborators of Paul H. Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul H. Huang. Paul H. Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Varma, Sushama, Jack Pengfei Tang, Danielle Graham, et al.. (2025). SCAN-ACT: adoptive T cell therapy target discovery through single-cell transcriptomics. Genome Medicine. 17(1). 89–89.

Pozas, Javier, Khin Thway, Daniel Lindsay, et al.. (2025). Ossifying fibromyxoid tumours: A case series. European Journal of Cancer. 217. 115229–115229.

Callegaro, Dario, Felix Boakye Oppong, Axelle Nzokirantevye, et al.. (2025). CINSARC and Sarculator in Patients with Primary Retroperitoneal Sarcoma: A Combined Analysis of Single-Institution Data and the EORTC-STBSG-62092 Trial (STRASS). Clinical Cancer Research. 31(15). 3239–3248.

Jenks, Andrew, et al.. (2025). Exploiting collateral sensitivity in the evolution of resistance to tyrosine kinase inhibitors in soft tissue sarcomas. Communications Biology. 8(1). 1185–1185.

Huang, Paul H., et al.. (2025). Curcumin delivered by ROS-responsive ibuprofen prodrug based on hyaluronic acid effectively suppressed the rheumatoid arthritis. Journal of Drug Delivery Science and Technology. 108. 106868–106868. 2 indexed citations

Thway, Khin, Sandro Pasquali, Dario Callegaro, et al.. (2024). Opportunities and Challenges in Soft Tissue Sarcoma Risk Stratification in the Era of Personalised Medicine. Current Treatment Options in Oncology. 25(8). 1124–1135. 2 indexed citations

Krásný, Lukáš, Jessica Burns, Emma Perkins, et al.. (2024). Clinical Implications and Molecular Features of Extracellular Matrix Networks in Soft Tissue Sarcomas. Clinical Cancer Research. 30(15). 3229–3242. 3 indexed citations

Jenks, Andrew, Jessica Burns, Priya Chudasama, et al.. (2024). Proteomic profiling improves prognostic risk stratification of the Sarculator nomogram in soft tissue sarcomas of the extremities and trunk wall. Cancer Medicine. 13(14). e70026–e70026. 3 indexed citations

Burns, Jessica, Tom Wei‐Wu Chen, Khin Thway, et al.. (2024). Proteomic features of soft tissue tumours in adolescents and young adults. SHILAP Revista de lepidopterología. 4(1). 93–93. 2 indexed citations

10.

Thway, Khin, et al.. (2023). The biology and treatment of leiomyosarcomas. Critical Reviews in Oncology/Hematology. 184. 103955–103955. 4 indexed citations

11.

Stacchiotti, Silvia, Giacomo Giulio Baldi, Anna Maria Frezza, et al.. (2023). Regorafenib in advanced solitary fibrous tumour: Results from an exploratory phase II clinical study. European Journal of Cancer. 195. 113391–113391. 8 indexed citations

12.

Smrke, Alannah, Aisha Miah, Khin Thway, et al.. (2022). Systemic therapy is effective in the management of leiomyomatosis. European Journal of Gynaecological Oncology. 43(3). 83–83.

13.

Ning, Jian, Lukáš Krásný, Amanda Swain, et al.. (2022). Characterisation of a Novel Cell Line (ICR-SS-1) Established from a Patient-Derived Xenograft of Synovial Sarcoma. Cells. 11(15). 2418–2418. 1 indexed citations

14.

Krásný, Lukáš, Emma Perkins, Andrew Jenks, et al.. (2022). Proteomic Profiling Identifies Co-Regulated Expression of Splicing Factors as a Characteristic Feature of Intravenous Leiomyomatosis. Cancers. 14(12). 2907–2907. 3 indexed citations

15.

Krásný, Lukáš & Paul H. Huang. (2021). Advances in the proteomic profiling of the matrisome and adhesome. Expert Review of Proteomics. 18(9). 781–794. 20 indexed citations

16.

Krásný, Lukáš & Paul H. Huang. (2020). Data-independent acquisition mass spectrometry (DIA-MS) for proteomic applications in oncology. Molecular Omics. 17(1). 29–42. 128 indexed citations

17.

Chen, Tom Wei‐Wu, Jessica Burns, Robin L. Jones, & Paul H. Huang. (2020). Optimal Clinical Management and the Molecular Biology of Angiosarcomas. Cancers. 12(11). 3321–3321. 14 indexed citations

18.

Jenks, Andrew, Simon Vyse, Eleftherios Kostaras, et al.. (2018). Primary Cilia Mediate Diverse Kinase Inhibitor Resistance Mechanisms in Cancer. Cell Reports. 23(10). 3042–3055. 89 indexed citations

19.

Huang, Paul H., et al.. (2017). Progress and impact of clinical phosphoproteomics on precision oncology. Translational Cancer Research. 6. 1 indexed citations

20.

Xu, Alexander M. & Paul H. Huang. (2010). Receptor Tyrosine Kinase Coactivation Networks in Cancer. Cancer Research. 70(10). 3857–3860. 140 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact